Tibet Cheezheng Tibetan Medicine Co Ltd (002287) — Financial Flexibility Index
Tibet Cheezheng Tibetan Medicine Co Ltd (002287) has a Financial Flexibility Index of 0.04x as of September 2025. Free cash flow of CN¥76.38 Million (operating CF CN¥34.69 Million minus capex CN¥41.69 Million) represents 0% of total liabilities (CN¥1.78 Billion). Check 002287 capital-intensive asset ratio to assess the company's strategic physical and investment asset allocation.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Tibet Cheezheng Tibetan Medicine Co Ltd Financial Flexibility Index (2006–2025)
Historical Financial Flexibility Index trend for Tibet Cheezheng Tibetan Medicine Co Ltd across 20 annual periods. See 002287 net working capital ratio to evaluate short-term liquidity relative to the company's equity base.
Annual Financial Flexibility Index for Tibet Cheezheng Tibetan Medicine Co Ltd (2006–2025)
Year-by-year free cash flow to debt coverage for Tibet Cheezheng Tibetan Medicine Co Ltd. For the full company profile including market capitalisation, see 002287 market cap overview.
| Year | Flexibility Index | Free Cash Flow (CNY) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.46x | CN¥882.78 Million | CN¥729.70 Million | CN¥1.92 Billion | ▲ +72.8% |
| 2024 | 0.27x | CN¥712.19 Million | CN¥456.75 Million | CN¥2.68 Billion | ▼ -27.5% |
| 2023 | 0.37x | CN¥928.22 Million | CN¥693.41 Million | CN¥2.53 Billion | ▲ +64.4% |
| 2022 | 0.22x | CN¥558.08 Million | CN¥285.69 Million | CN¥2.50 Billion | ▼ -54.8% |
| 2021 | 0.49x | CN¥1.16 Billion | CN¥1.03 Billion | CN¥2.35 Billion | ▲ +56.2% |
| 2020 | 0.32x | CN¥577.62 Million | CN¥238.65 Million | CN¥1.82 Billion | ▼ -50.1% |
| 2019 | 0.63x | CN¥458.22 Million | CN¥405.95 Million | CN¥722.20 Million | ▼ -73.0% |
| 2018 | 2.35x | CN¥628.34 Million | CN¥499.40 Million | CN¥267.54 Million | ▲ +219.6% |
| 2017 | 0.73x | CN¥295.95 Million | CN¥229.83 Million | CN¥402.78 Million | ▼ -58.1% |
| 2016 | 1.75x | CN¥569.08 Million | CN¥389.20 Million | CN¥324.33 Million | ▲ +127.8% |
| 2015 | 0.77x | CN¥322.72 Million | CN¥257.81 Million | CN¥419.05 Million | ▼ -52.5% |
| 2014 | 1.62x | CN¥392.42 Million | CN¥310.95 Million | CN¥242.20 Million | ▼ -48.7% |
| 2013 | 3.16x | CN¥272.86 Million | CN¥198.48 Million | CN¥86.34 Million | ▲ +10.5% |
| 2012 | 2.86x | CN¥231.32 Million | CN¥169.67 Million | CN¥80.90 Million | ▲ +204.0% |
| 2011 | 0.94x | CN¥75.25 Million | CN¥-11.74 Million | CN¥80.01 Million | ▼ -32.5% |
| 2010 | 1.39x | CN¥154.23 Million | CN¥96.91 Million | CN¥110.72 Million | ▲ +10.8% |
| 2009 | 1.26x | CN¥192.02 Million | CN¥175.58 Million | CN¥152.68 Million | ▲ +38.8% |
| 2008 | 0.91x | CN¥89.72 Million | CN¥65.93 Million | CN¥99.02 Million | ▼ -12.0% |
| 2007 | 1.03x | CN¥121.92 Million | CN¥91.43 Million | CN¥118.37 Million | ▲ +164.1% |
| 2006 | 0.39x | CN¥52.40 Million | CN¥38.50 Million | CN¥134.37 Million | — |